The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism

Autores
Sebastián, Carlos; Zwaans, Bernardette M. M.; Silberman, Dafne Magali; Gymrek, Melissa; Goren, Alon; Zhong, Lei; Ram, Oren; Truelove, Jessica; Guimaraes, Alexander R.; Toiber, Debra; Cosentino, Claudia; Greenson, Joel K.; MacDonald, Alasdair I.; McGlynn, Liane; Maxwell, Fraser; Edwards, Joanne; Giacosa, Sofía; Guccione, Ernesto; Weissleder, Ralph; Bernstein, Bradley E.; Regev, Aviv; Shiels, Paul G.; Lombard, David B.; Mostoslavsky, Raul
Año de publicación
2012
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.
Fil: Sebastián, Carlos. Harvard Medical School; Estados Unidos
Fil: Zwaans, Bernardette M. M.. University of Michigan; Estados Unidos
Fil: Silberman, Dafne Magali. Harvard Medical School; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Gymrek, Melissa. Massachusetts Institute of Technology; Estados Unidos
Fil: Goren, Alon. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados Unidos
Fil: Zhong, Lei. Harvard Medical School; Estados Unidos
Fil: Ram, Oren. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados Unidos
Fil: Truelove, Jessica. The Massachusetts General Hospital; Estados Unidos
Fil: Guimaraes, Alexander R.. The Massachusetts General Hospital; Estados Unidos
Fil: Toiber, Debra. Harvard Medical School; Estados Unidos
Fil: Cosentino, Claudia. Harvard Medical School; Estados Unidos
Fil: Greenson, Joel K.. University of Michigan; Estados Unidos
Fil: MacDonald, Alasdair I.. University of Glasgow; Reino Unido
Fil: McGlynn, Liane. University of Glasgow; Reino Unido
Fil: Maxwell, Fraser. University of Glasgow; Reino Unido
Fil: Edwards, Joanne. University of Glasgow; Reino Unido
Fil: Giacosa, Sofía. Harvard Medical School; Estados Unidos
Fil: Guccione, Ernesto. Institute of Molecular and Cell Biology; Singapur
Fil: Weissleder, Ralph. The Massachusetts General Hospital; Estados Unidos
Fil: Bernstein, Bradley E.. Harvard Medical School; Estados Unidos
Fil: Regev, Aviv. Harvard Medical School; Estados Unidos
Fil: Shiels, Paul G.. University of Glasgow; Reino Unido
Fil: Lombard, David B.. University of Michigan; Estados Unidos
Fil: Mostoslavsky, Raul. Harvard Medical School; Estados Unidos
Materia
Sirt6
Cancer
Metabolism
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/17712

id CONICETDig_6920e5524884f257c9eaac41ee8685ec
oai_identifier_str oai:ri.conicet.gov.ar:11336/17712
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolismSebastián, CarlosZwaans, Bernardette M. M.Silberman, Dafne MagaliGymrek, MelissaGoren, AlonZhong, LeiRam, OrenTruelove, JessicaGuimaraes, Alexander R.Toiber, DebraCosentino, ClaudiaGreenson, Joel K.MacDonald, Alasdair I.McGlynn, LianeMaxwell, FraserEdwards, JoanneGiacosa, SofíaGuccione, ErnestoWeissleder, RalphBernstein, Bradley E.Regev, AvivShiels, Paul G.Lombard, David B.Mostoslavsky, RaulSirt6CancerMetabolismhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.Fil: Sebastián, Carlos. Harvard Medical School; Estados UnidosFil: Zwaans, Bernardette M. M.. University of Michigan; Estados UnidosFil: Silberman, Dafne Magali. Harvard Medical School; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; ArgentinaFil: Gymrek, Melissa. Massachusetts Institute of Technology; Estados UnidosFil: Goren, Alon. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados UnidosFil: Zhong, Lei. Harvard Medical School; Estados UnidosFil: Ram, Oren. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados UnidosFil: Truelove, Jessica. The Massachusetts General Hospital; Estados UnidosFil: Guimaraes, Alexander R.. The Massachusetts General Hospital; Estados UnidosFil: Toiber, Debra. Harvard Medical School; Estados UnidosFil: Cosentino, Claudia. Harvard Medical School; Estados UnidosFil: Greenson, Joel K.. University of Michigan; Estados UnidosFil: MacDonald, Alasdair I.. University of Glasgow; Reino UnidoFil: McGlynn, Liane. University of Glasgow; Reino UnidoFil: Maxwell, Fraser. University of Glasgow; Reino UnidoFil: Edwards, Joanne. University of Glasgow; Reino UnidoFil: Giacosa, Sofía. Harvard Medical School; Estados UnidosFil: Guccione, Ernesto. Institute of Molecular and Cell Biology; SingapurFil: Weissleder, Ralph. The Massachusetts General Hospital; Estados UnidosFil: Bernstein, Bradley E.. Harvard Medical School; Estados UnidosFil: Regev, Aviv. Harvard Medical School; Estados UnidosFil: Shiels, Paul G.. University of Glasgow; Reino UnidoFil: Lombard, David B.. University of Michigan; Estados UnidosFil: Mostoslavsky, Raul. Harvard Medical School; Estados UnidosElsevier2012-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/17712Sebastián, Carlos; Zwaans, Bernardette M. M.; Silberman, Dafne Magali; Gymrek, Melissa; Goren, Alon; et al.; The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism; Elsevier; Cell; 151; 6; 12-2012; 1185-11990092-8674enginfo:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0092867412013517info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cell.2012.10.047info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:02:40Zoai:ri.conicet.gov.ar:11336/17712instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:02:41.075CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
title The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
spellingShingle The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
Sebastián, Carlos
Sirt6
Cancer
Metabolism
title_short The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
title_full The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
title_fullStr The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
title_full_unstemmed The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
title_sort The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
dc.creator.none.fl_str_mv Sebastián, Carlos
Zwaans, Bernardette M. M.
Silberman, Dafne Magali
Gymrek, Melissa
Goren, Alon
Zhong, Lei
Ram, Oren
Truelove, Jessica
Guimaraes, Alexander R.
Toiber, Debra
Cosentino, Claudia
Greenson, Joel K.
MacDonald, Alasdair I.
McGlynn, Liane
Maxwell, Fraser
Edwards, Joanne
Giacosa, Sofía
Guccione, Ernesto
Weissleder, Ralph
Bernstein, Bradley E.
Regev, Aviv
Shiels, Paul G.
Lombard, David B.
Mostoslavsky, Raul
author Sebastián, Carlos
author_facet Sebastián, Carlos
Zwaans, Bernardette M. M.
Silberman, Dafne Magali
Gymrek, Melissa
Goren, Alon
Zhong, Lei
Ram, Oren
Truelove, Jessica
Guimaraes, Alexander R.
Toiber, Debra
Cosentino, Claudia
Greenson, Joel K.
MacDonald, Alasdair I.
McGlynn, Liane
Maxwell, Fraser
Edwards, Joanne
Giacosa, Sofía
Guccione, Ernesto
Weissleder, Ralph
Bernstein, Bradley E.
Regev, Aviv
Shiels, Paul G.
Lombard, David B.
Mostoslavsky, Raul
author_role author
author2 Zwaans, Bernardette M. M.
Silberman, Dafne Magali
Gymrek, Melissa
Goren, Alon
Zhong, Lei
Ram, Oren
Truelove, Jessica
Guimaraes, Alexander R.
Toiber, Debra
Cosentino, Claudia
Greenson, Joel K.
MacDonald, Alasdair I.
McGlynn, Liane
Maxwell, Fraser
Edwards, Joanne
Giacosa, Sofía
Guccione, Ernesto
Weissleder, Ralph
Bernstein, Bradley E.
Regev, Aviv
Shiels, Paul G.
Lombard, David B.
Mostoslavsky, Raul
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Sirt6
Cancer
Metabolism
topic Sirt6
Cancer
Metabolism
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.
Fil: Sebastián, Carlos. Harvard Medical School; Estados Unidos
Fil: Zwaans, Bernardette M. M.. University of Michigan; Estados Unidos
Fil: Silberman, Dafne Magali. Harvard Medical School; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Gymrek, Melissa. Massachusetts Institute of Technology; Estados Unidos
Fil: Goren, Alon. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados Unidos
Fil: Zhong, Lei. Harvard Medical School; Estados Unidos
Fil: Ram, Oren. Harvard Medical School; Estados Unidos. Massachusetts Institute of Technology; Estados Unidos
Fil: Truelove, Jessica. The Massachusetts General Hospital; Estados Unidos
Fil: Guimaraes, Alexander R.. The Massachusetts General Hospital; Estados Unidos
Fil: Toiber, Debra. Harvard Medical School; Estados Unidos
Fil: Cosentino, Claudia. Harvard Medical School; Estados Unidos
Fil: Greenson, Joel K.. University of Michigan; Estados Unidos
Fil: MacDonald, Alasdair I.. University of Glasgow; Reino Unido
Fil: McGlynn, Liane. University of Glasgow; Reino Unido
Fil: Maxwell, Fraser. University of Glasgow; Reino Unido
Fil: Edwards, Joanne. University of Glasgow; Reino Unido
Fil: Giacosa, Sofía. Harvard Medical School; Estados Unidos
Fil: Guccione, Ernesto. Institute of Molecular and Cell Biology; Singapur
Fil: Weissleder, Ralph. The Massachusetts General Hospital; Estados Unidos
Fil: Bernstein, Bradley E.. Harvard Medical School; Estados Unidos
Fil: Regev, Aviv. Harvard Medical School; Estados Unidos
Fil: Shiels, Paul G.. University of Glasgow; Reino Unido
Fil: Lombard, David B.. University of Michigan; Estados Unidos
Fil: Mostoslavsky, Raul. Harvard Medical School; Estados Unidos
description Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.
publishDate 2012
dc.date.none.fl_str_mv 2012-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/17712
Sebastián, Carlos; Zwaans, Bernardette M. M.; Silberman, Dafne Magali; Gymrek, Melissa; Goren, Alon; et al.; The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism; Elsevier; Cell; 151; 6; 12-2012; 1185-1199
0092-8674
url http://hdl.handle.net/11336/17712
identifier_str_mv Sebastián, Carlos; Zwaans, Bernardette M. M.; Silberman, Dafne Magali; Gymrek, Melissa; Goren, Alon; et al.; The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism; Elsevier; Cell; 151; 6; 12-2012; 1185-1199
0092-8674
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0092867412013517
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cell.2012.10.047
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613833554919424
score 13.070432